Annual CFO
-$4.76 M
+$1.85 M+27.99%
December 31, 2023
Summary
- As of February 12, 2025, INVO annual cash flow from operations is -$4.76 million, with the most recent change of +$1.85 million (+27.99%) on December 31, 2023.
- During the last 3 years, INVO annual CFO has risen by +$20.00 thousand (+0.42%).
Performance
INVO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$640.81 K
+$814.89 K+55.98%
September 30, 2024
Summary
- As of February 12, 2025, INVO quarterly cash flow from operations is -$640.81 thousand, with the most recent change of +$814.89 thousand (+55.98%) on September 30, 2024.
- Over the past year, INVO quarterly CFO has dropped by -$380.21 thousand (-145.90%).
Performance
INVO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$3.07 M
+$606.49 K+16.49%
September 30, 2024
Summary
- As of February 12, 2025, INVO TTM cash flow from operations is -$3.07 million, with the most recent change of +$606.49 thousand (+16.49%) on September 30, 2024.
- Over the past year, INVO TTM CFO has increased by +$795.19 thousand (+20.56%).
Performance
INVO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
INVO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.0% | -145.9% | +20.6% |
| 3 y3 years | +0.4% | +69.2% | +51.8% |
| 5 y5 years | -628.2% | +69.2% | +51.8% |
INVO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.9% | +145.9% | +224.3% | at high | +131.5% |
| 5 y | 5-year | -447.0% | +38.9% | +145.9% | +224.3% | -324.2% | +131.5% |
| alltime | all time | -447.0% | +38.9% | -120.8% | +224.3% | -224.2% | +131.5% |
INVO Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$640.81 K(-56.0%) | -$3.07 M(-16.5%) |
| Jun 2024 | - | -$1.46 M(+458.6%) | -$3.68 M(-4.9%) |
| Mar 2024 | - | -$260.60 K(-63.5%) | -$3.87 M(-18.7%) |
| Dec 2023 | -$4.76 M(-28.0%) | -$714.90 K(-42.7%) | -$4.76 M(-5.7%) |
| Sep 2023 | - | -$1.25 M(-24.1%) | -$5.04 M(-7.4%) |
| Jun 2023 | - | -$1.64 M(+43.2%) | -$5.45 M(-4.0%) |
| Mar 2023 | - | -$1.15 M(+14.4%) | -$5.67 M(-14.1%) |
| Dec 2022 | -$6.60 M(+9.5%) | -$1.00 M(-39.1%) | -$6.60 M(-7.1%) |
| Sep 2022 | - | -$1.65 M(-12.0%) | -$7.11 M(+0.5%) |
| Jun 2022 | - | -$1.87 M(-9.9%) | -$7.07 M(+11.0%) |
| Mar 2022 | - | -$2.08 M(+37.5%) | -$6.37 M(+5.7%) |
| Dec 2021 | -$6.03 M(+26.3%) | -$1.51 M(-6.1%) | -$6.03 M(-4.9%) |
| Sep 2021 | - | -$1.61 M(+37.1%) | -$6.34 M(+11.8%) |
| Jun 2021 | - | -$1.17 M(-32.4%) | -$5.67 M(+0.4%) |
| Mar 2021 | - | -$1.74 M(-4.7%) | -$5.65 M(+18.3%) |
| Dec 2020 | -$4.78 M(-448.4%) | -$1.82 M(+93.6%) | -$4.78 M(+28.2%) |
| Sep 2020 | - | -$940.40 K(-18.3%) | -$3.73 M(+11.1%) |
| Jun 2020 | - | -$1.15 M(+33.3%) | -$3.35 M(+30.0%) |
| Mar 2020 | - | -$863.50 K(+12.0%) | -$2.58 M(-288.3%) |
| Dec 2019 | $1.37 M(-309.9%) | -$771.10 K(+35.6%) | $1.37 M(-26.1%) |
| Sep 2019 | - | -$568.60 K(+50.5%) | $1.86 M(-19.6%) |
| Jun 2019 | - | -$377.90 K(-112.2%) | $2.31 M(-6.7%) |
| Mar 2019 | - | $3.09 M(-1178.6%) | $2.47 M(-478.6%) |
| Dec 2018 | -$653.00 K(+260.2%) | -$286.30 K(+144.5%) | -$653.00 K(+69.1%) |
| Sep 2018 | - | -$117.10 K(-44.8%) | -$386.20 K(+30.3%) |
| Jun 2018 | - | -$212.20 K(+467.4%) | -$296.50 K(+180.0%) |
| Mar 2018 | - | -$37.40 K(+91.8%) | -$105.90 K(-41.6%) |
| Dec 2017 | -$181.30 K(-44.0%) | -$19.50 K(-28.8%) | -$181.30 K(-30.3%) |
| Sep 2017 | - | -$27.40 K(+26.9%) | -$260.30 K(-10.2%) |
| Jun 2017 | - | -$21.60 K(-80.9%) | -$289.90 K(-21.2%) |
| Mar 2017 | - | -$112.80 K(+14.5%) | -$368.00 K(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$323.90 K(+113.7%) | -$98.50 K(+72.8%) | -$323.90 K(-1.3%) |
| Sep 2016 | - | -$57.00 K(-42.8%) | -$328.00 K(+10.8%) |
| Jun 2016 | - | -$99.70 K(+45.1%) | -$296.10 K(+47.2%) |
| Mar 2016 | - | -$68.70 K(-33.0%) | -$201.20 K(+32.6%) |
| Dec 2015 | -$151.60 K(+681.4%) | -$102.60 K(+308.8%) | -$151.70 K(+209.0%) |
| Sep 2015 | - | -$25.10 K(+422.9%) | -$49.10 K(+104.6%) |
| Jun 2015 | - | -$4800.00(-75.0%) | -$24.00 K(+25.0%) |
| Mar 2015 | - | -$19.20 K(-141.5%) | -$19.20 K(-83.7%) |
| Dec 2014 | -$19.40 K(-67.6%) | - | - |
| Dec 2013 | -$59.90 K(+38.7%) | - | - |
| Dec 2012 | -$43.20 K(-63.3%) | - | - |
| Dec 2011 | -$117.80 K(-62.7%) | $46.30 K(-179.4%) | -$117.70 K(+140.2%) |
| Sep 2011 | - | -$58.30 K(+36.9%) | -$49.00 K(-62.7%) |
| Jun 2011 | - | -$42.60 K(-32.5%) | -$131.40 K(-33.2%) |
| Mar 2011 | - | -$63.10 K(-154.9%) | -$196.80 K(-37.7%) |
| Dec 2010 | -$316.00 K(-65.9%) | $115.00 K(-181.7%) | -$316.10 K(-53.8%) |
| Sep 2010 | - | -$140.70 K(+30.3%) | -$684.50 K(-21.2%) |
| Jun 2010 | - | -$108.00 K(-40.8%) | -$868.50 K(+4.9%) |
| Mar 2010 | - | -$182.40 K(-28.0%) | -$828.20 K(-10.6%) |
| Dec 2009 | -$926.70 K(-13.1%) | -$253.40 K(-22.0%) | -$926.80 K(-46.2%) |
| Sep 2009 | - | -$324.70 K(+379.6%) | -$1.72 M(+37.2%) |
| Jun 2009 | - | -$67.70 K(-75.9%) | -$1.26 M(-6.0%) |
| Mar 2009 | - | -$281.00 K(-73.2%) | -$1.34 M(+25.3%) |
| Dec 2008 | -$1.07 M(+8168.2%) | -$1.05 M(-836.6%) | -$1.07 M(+5728.4%) |
| Sep 2008 | - | $142.50 K(-196.3%) | -$18.30 K(-88.7%) |
| Jun 2008 | - | -$147.90 K(+1186.1%) | -$162.20 K(+567.5%) |
| Mar 2008 | - | -$11.50 K(+721.4%) | -$24.30 K(+86.9%) |
| Dec 2007 | -$12.90 K(+1190.0%) | -$1400.00(0.0%) | -$13.00 K(+12.1%) |
| Sep 2007 | - | -$1400.00(-86.0%) | -$11.60 K(+13.7%) |
| Jun 2007 | - | -$10.00 K(+4900.0%) | -$10.20 K(+5000.0%) |
| Mar 2007 | - | -$200.00 | -$200.00 |
| Dec 2006 | -$1000.00 | - | - |
FAQ
- What is INVO Bioscience annual cash flow from operations?
- What is the all time high annual CFO for INVO Bioscience?
- What is INVO Bioscience annual CFO year-on-year change?
- What is INVO Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for INVO Bioscience?
- What is INVO Bioscience quarterly CFO year-on-year change?
- What is INVO Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for INVO Bioscience?
- What is INVO Bioscience TTM CFO year-on-year change?
What is INVO Bioscience annual cash flow from operations?
The current annual CFO of INVO is -$4.76 M
What is the all time high annual CFO for INVO Bioscience?
INVO Bioscience all-time high annual cash flow from operations is $1.37 M
What is INVO Bioscience annual CFO year-on-year change?
Over the past year, INVO annual cash flow from operations has changed by +$1.85 M (+27.99%)
What is INVO Bioscience quarterly cash flow from operations?
The current quarterly CFO of INVO is -$640.81 K
What is the all time high quarterly CFO for INVO Bioscience?
INVO Bioscience all-time high quarterly cash flow from operations is $3.09 M
What is INVO Bioscience quarterly CFO year-on-year change?
Over the past year, INVO quarterly cash flow from operations has changed by -$380.21 K (-145.90%)
What is INVO Bioscience TTM cash flow from operations?
The current TTM CFO of INVO is -$3.07 M
What is the all time high TTM CFO for INVO Bioscience?
INVO Bioscience all-time high TTM cash flow from operations is $2.47 M
What is INVO Bioscience TTM CFO year-on-year change?
Over the past year, INVO TTM cash flow from operations has changed by +$795.19 K (+20.56%)